Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level.
Huang
Jocelin
J
Tefferi
Ayalew
A
D000368:Aged; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000188:drug therapy*
D006397:Hematinics; D004921:Erythropoietin